| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.296 | 1.274 | 2.129 | 3.555 | 2.659 | 3.671 | 2.555 | 3.631 | 1.206 | 4.751 |
| Total Income - EUR | 1.296 | 1.274 | 2.149 | 3.567 | 2.664 | 3.671 | 2.659 | 3.637 | 1.206 | 4.751 |
| Total Expenses - EUR | 244 | 326 | 2.071 | 2.646 | 1.663 | 3.049 | 2.901 | 2.230 | 1.387 | 1.225 |
| Gross Profit/Loss - EUR | 1.052 | 949 | 78 | 922 | 1.001 | 622 | -242 | 1.407 | -181 | 3.526 |
| Net Profit/Loss - EUR | 1.013 | 910 | 13 | 814 | 923 | 622 | -242 | 1.381 | -215 | 3.390 |
| Employees | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Artrosan Med S.r.l.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 661 | 568 | 0 | 0 | 0 | 0 | 467 | 2.509 | 1.782 | 1.054 |
| Current Assets | 1.205 | 2.148 | 2.075 | 2.741 | 3.598 | 4.191 | 3.422 | 2.753 | 3.254 | 7.312 |
| Inventories | 389 | 341 | 335 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 815 | 1.806 | 1.740 | 2.741 | 3.598 | 4.191 | 3.422 | 2.753 | 3.254 | 7.312 |
| Shareholders Funds | 1.057 | 1.950 | 1.927 | 2.704 | 3.576 | 4.118 | 3.889 | 5.258 | 5.014 | 8.337 |
| Social Capital | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 | 0 |
| Debts | 809 | 766 | 148 | 36 | 22 | 73 | 0 | 4 | 22 | 28 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 5.0415 | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Artrosan Med S.r.l.